The Clorox Company $CLX Stock Bought by Venture Visionary Partners LLC

Key Points

• Venture Visionary Partners increased its Clorox stake by 51.9% in the third quarter, bringing its holdings to 55,522 shares valued at approximately $4.6 million. Institutional investors collectively own 78.53% of CLX.
• Clorox reported quarterly revenue of $1.95 billion and EPS of $1.66, slightly exceeding analyst expectations, though revenue declined 2% year over year. The company set fiscal 2027 EPS guidance at $5.70–$6.00.
• Clorox declared a quarterly dividend of $1.25 per share, equivalent to $5.00 annually and a 6.1% yield. Analyst sentiment remains cautious, with a consensus “Reduce” rating and an average price target of $99.36.

Venture Visionary Partners LLC increased its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 51.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 55,522 shares of the company's stock after acquiring an additional 18,982 shares during the quarter. Venture Visionary Partners LLC's holdings in Clorox were worth $4,625,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of CLX. BlackRock Inc. bought a new stake in Clorox in the second quarter valued at approximately $958,640,000. Van ECK Associates Corp grew its holdings in shares of Clorox by 15.7% in the fourth quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company's stock worth $316,244,000 after purchasing an additional 426,433 shares during the last quarter. Bank of America Corp DE purchased a new position in shares of Clorox in the second quarter worth $179,780,000. Arrowstreet Capital Limited Partnership increased its stake in shares of Clorox by 9.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,619,396 shares of the company's stock worth $163,284,000 after buying an additional 142,463 shares during the period. Finally, Royal Bank of Canada raised its holdings in Clorox by 20.1% during the 1st quarter. Royal Bank of Canada now owns 1,418,204 shares of the company's stock valued at $146,969,000 after buying an additional 237,301 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of CLX stock opened at $82.12 on Thursday. The firm has a market capitalization of $9.93 billion, a price-to-earnings ratio of 17.04, a PEG ratio of 2.63 and a beta of 0.59. The stock has a fifty day moving average of $94.63 and a 200 day moving average of $96.17. The Clorox Company has a 52 week low of $79.12 and a 52 week high of $128.90. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. During the same period in the previous year, the firm earned $2.87 EPS. The company's quarterly revenue was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, research analysts expect that The Clorox Company will post 5.77 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Wednesday, October 28th will be given a dividend of $1.25 per share. The ex-dividend date is Wednesday, October 28th. This represents a $5.00 annualized dividend and a dividend yield of 6.1%. Clorox's payout ratio is currently 103.73%.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft set a $98.00 price target on shares of Clorox in a research report on Tuesday, August 4th. BNP Paribas Exane lowered their price objective on shares of Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a research note on Monday, July 20th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Clorox in a report on Friday, July 10th. Wall Street Zen lowered shares of Clorox from a "hold" rating to a "sell" rating in a report on Saturday, October 3rd. Finally, JPMorgan Chase & Co. raised their target price on Clorox from $92.00 to $95.00 and gave the stock an "underweight" rating in a research note on Tuesday, August 4th. Twelve investment analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, Clorox has a consensus rating of "Reduce" and an average price target of $99.36.

About Clorox

The Clorox Company is a consumer and professional products company that develops, manufactures and markets household cleaning, disinfecting, wellness and personal care products. Its portfolio includes the Clorox bleach and cleaning brands, as well as products sold under brands such as Pine-Sol, Liquid-Plumr, Fresh Step, Scoop Away, Kingsford, Hidden Valley, Burt's Bees and Brita.

Clorox also offers trash bags, food products, water-filtration systems, charcoal and grilling products, cat litter, and professional cleaning and disinfecting solutions.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.